Vivimed Labs gains after reporting decent Q1 results

Vivimed Labs rose 3.58% to Rs 75.25 at 10:21 IST on BSE after consolidated net profit rose 15.3% to Rs 27.86 crore on 10.6% growth in net sales to Rs 366.83 crore in Q1 June 2016 over Q1 June 2015.

The result was announced on Saturday, 13 August 2016.

Meanwhile, the S&P BSE Sensex was up 30.30 points or 0.11% at 28,182.70.

On BSE, so far 17,000 shares were traded in the counter as against average daily volume of 25,353 shares in the past one quarter. The stock hit a high of Rs 77.50 and a low of Rs 74.35 so far during the day. The stock had hit a record high of Rs 97 on 12 January 2016. The stock had hit a 52-week low of Rs 46.94 on 25 August 2015. The stock had underperformed the market over the past one month till 12 August 2016, sliding 7.8% compared with 1.24% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 14.13% as against Sensex's 9.16% rise.

 

The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 2.

Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.

Powered by Capital Market - Live News